The lymphoma cells can become resistant to treatment. In general, treatment is less likely to work each time your lymphoma comes back ( relapses). Your medical team are best-placed to talk through with you whether treatment is likely to help you. Is further active treatment likely to work?
anything else that is important to you – talk to your medical team about any other factors you’d like them to take into account. Your medical team also considers personal factors, such as: results of genetic tests – these can be useful with some types of lymphoma and can help guide your doctor on treatment choices. 
what parts of your body are affected by lymphoma. the type of lymphoma you have and its stage. Your medical team considers lymphoma-specific factors, such as: There are many factors to think about when deciding whether or not to continue with active treatment. This is known as ‘ palliative care’ and is separate to active treatment given to treat your lymphoma. This can include anything that’s important to you, for example, how you’d like to dress or what music you enjoy listening to.įrom the point of diagnosis onwards, you should be offered symptom and pain relief. You are also entitled to set out any wider preferences about your care by making an advance statement. This allows you to write down treatments you would or wouldn’t want in future, in case you become unable to communicate your preferences at the time that you need to. Some people choose to write an advance decision (‘living will’). This could be because the lymphoma does not respond to treatment, or you might not be well enough for more treatment. In some cases, doctors are unable to offer further treatment. Ultimately, the decision is between you and your medical team. You might or might not want to talk to friends and family members about it. How do I know when to stop active treatment?ĭeciding to end active treatment can be deeply emotional. Healthcare professionals Expand dropdown. Lotteries, prize draws and competitions. Fundraise with family, friends and colleagues. Sign up for education and training updates. Lymphoma TrialsLink (clinical trials database). Post-transplant lymphoproliferative disorder. 
youtube Youtube (opens in a new window). instagram Instagram (opens in a new window). facebook Facebook (opens in a new window). twitter Twitter (opens in a new window).
0 kommentar(er)
